TOURMALINE BIO INC (TRML) Stock Balance Sheet
NASDAQ:TRML - Nasdaq - US89157D1054 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 30.51M | 140.73M | 13.70M | 18.60M | 17.60M | |||
| Marketable Securities | 227.80M | 62.23M | 167.60M | 225.40M | 131.90M | |||
| Receivables | N/A | N/A | N/A | N/A | 400.00K | |||
| Other Current Assets | 10.54M | 5.92M | 4.40M | 2.50M | 900.00K | |||
| Total Current Assets | 268.84M | 208.87M | 185.60M | 246.50M | 150.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 267.00K | 570.00K | 8.00M | 4.80M | 2.00M | |||
| Investments And Advances | 36.63M | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 3.26M | 851.00K | 100.00K | 100.00K | 0.00 | |||
| Total Non-Current Assets | 40.16M | 1.42M | 8.10M | 4.90M | 2.00M | |||
| TOTAL ASSETS | 309.00M | 210.29M | 193.70M | 251.40M | 152.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 5.33M | 3.93M | 7.60M | 5.40M | 2.10M | |||
| Accounts Payable | 3.58M | 1.07M | 3.90M | 2.60M | 800.00K | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | 500.00K | |||
| Total Current Liabilities | 8.91M | 5.00M | 11.50M | 8.00M | 3.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 40.00K | 251.00K | 2.20M | 600.00K | 1.40M | |||
| Total Non-Current Liabilities | 40.00K | 251.00K | 2.20M | 600.00K | 1.40M | |||
| TOTAL LIABILITIES | 8.95M | 5.25M | 13.70M | 8.60M | 4.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -135.26M | -62.05M | -164.70M | -90.80M | -43.00M | |||
| Additional Paid In Capital | 435.01M | 267.02M | 345.50M | 333.70M | 4.90M | |||
| Common Shares | 3.00K | 2.00K | 0.00 | 0.00 | 186.20M | |||
| Shares Outstanding | 25.62M | 20.34M | 4.20M | 5.10M | 4.10M | |||
| Tangible Book Value per Share | 11.71 | 10.08 | 42.88 | 47.61 | -9.32 | |||
| Total Shareholders' Equity | 300.05M | 205.04M | 180.10M | 242.80M | 148.00M | |||
| TOTAL LIABILITIES AND EQUITY | 309.00M | 210.29M | 193.70M | 251.40M | 152.80M | |||
| Statistics | ||||||||
| Current Ratio | 30.18 | 41.76 | 16.14 | 30.81 | 44.35 | |||
| Return On Assets (ROA) | -23.69% | -20.03% | -38.15% | -19.03% | -14.86% | |||
| Return On Equity (ROE) | -24.40% | -20.54% | -41.03% | -19.70% | -15.34% | |||
All data in USD , ROIC based on taxRate of 0.21